Advertisement

Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction Categories

      There are no studies of long-term worsening renal function (WRF) in heart failure (HF) with different ejection fraction (EF) groups. The aim was to compare incidence of, associations with and prognostic impact of WRF in HF with preserved (HFpEF), mid-range (HFmrEF), and reduced EF (HFrEF). The Swedish Heart Failure Registry (SwedeHF) was merged with the Stockholm Creatinine Measurement (SCREAM) registry 2006 to 2010. The associations between EF and WRF (≥25% decrease in eGFR) and the associations between WRF25-49% and WRF≥50% within year one and subsequent all-cause mortality were all assessed with multiadjusted Cox regression. Of 7,154 patients, 41.6% of HFpEF versus 34.5% and 35.4% of HFmrEF and HFrEF patients developed WRF≥25% during year one. The WRF risk was higher in HFpEF (reference) than in HFmrEF, hazard ratio (95% confidence interval) 0.890 (0.794 to 0.997) and HFrEF 0.870 (0.784 to 0.965). WRF within year one was strongly associated with subsequent long-term mortality in all EF groups, yielding adjusted HRs with WRF25-49% and WRF≥50%: HFpEF, 1.101 (0.913 to 1.328) and 2.096 (1.652 to 2.659), in HFmrEF 1.654 (1.353 to 2.022) and 2.375 (1.807 to 3.122) and in HFrEF 1.212 (1.060 to 1.386) and 1.694 (1.412 to 2.033). In conclusion, the long-term WRF risk was high in HF and highest in HFpEF. WRF was strongly associated with mortality in all EF groups, although in HFpEF only with the most severe WRF.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hillege HL
        • Nitsch D
        • Pfeffer MA
        • Swedberg K
        • McMurray JJ
        • Yusuf S
        • Granger CB
        • Michelson EL
        • Ostergren J
        • Cornel JH
        • de Zeeuw D
        • Pocock S
        • van Veldhuisen DJ
        Candesartan in heart failure: assessment of reduction in M, morbidity I. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
        Circulation. 2006; 113: 671-678
        • Lofman I
        • Szummer K
        • Hagerman I
        • Dahlstrom U
        • Lund LH
        • Jernberg T
        Prevalence and prognostic impact of kidney disease on heart failure patients.
        Open heart. 2016; 3e000324
        • Metra M
        • Nodari S
        • Parrinello G
        • Bordonali T
        • Bugatti S
        • Danesi R
        • Fontanella B
        • Lombardi C
        • Milani P
        • Verzura G
        • Cotter G
        • Dittrich H
        • Massie BM
        • Dei Cas L
        Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.
        Eur J Heart Fail. 2008; 10: 188-195
        • Damman K
        • Tang WH
        • Testani JM
        • McMurray JJ
        Terminology and definition of changes renal function in heart failure.
        Eur Heart J. 2014; 35: 3413-3416
        • de Silva R
        • Nikitin NP
        • Witte KK
        • Rigby AS
        • Goode K
        • Bhandari S
        • Clark AL
        • Cleland JG
        Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis.
        Eur Heart J. 2006; 27: 569-581
        • Damman K
        • Masson S
        • Lucci D
        • Gorini M
        • Urso R
        • Maggioni AP
        • Tavazzi L
        • Tarantini L
        • Tognoni G
        • Voors A
        • Latini R
        Progression of renal impairment and chronic kidney disease in chronic heart failure: an analysis from GISSI-HF.
        J Card Fail. 2017; 23: 2-9
        • Blair JE
        • Pang PS
        • Schrier RW
        • Metra M
        • Traver B
        • Cook T
        • Campia U
        • Ambrosy A
        • Burnett Jr., JC
        • Grinfeld L
        • Maggioni AP
        • Swedberg K
        • Udelson JE
        • Zannad F
        • Konstam MA
        • Gheorghiade M
        • Investigators E
        Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
        Eur Heart J. 2011; 32: 2563-2572
        • Damman K
        • Jaarsma T
        • Voors AA
        • Navis G
        • Hillege HL
        • van Veldhuisen DJ
        • investigators C
        Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
        Eur J Heart Fail. 2009; 11: 847-854
        • Forman DE
        • Butler J
        • Wang Y
        • Abraham WT
        • O'Connor CM
        • Gottlieb SS
        • Loh E
        • Massie BM
        • Rich MW
        • Stevenson LW
        • Young JB
        • Krumholz HM
        Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
        J Am Coll of Cardiol. 2004; 43: 61-67
        • Damman K
        • Valente MA
        • Voors AA
        • O'Connor CM
        • van Veldhuisen DJ
        • Hillege HL
        Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.
        Eur Heart J. 2014; 35: 455-469
        • Metra M
        • Cotter G
        • Gheorghiade M
        • Dei Cas L
        • Voors AA
        The role of the kidney in heart failure.
        Eur Heart J. 2012; 33: 2135-2142
        • Paulus WJ
        • Tschope C.
        A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
        J Am Coll of Cardiol. 2013; 62: 263-271
        • Ponikowski P
        • Voors AA
        • Anker SD
        • Bueno H
        • Cleland JG
        • Coats AJ
        • Falk V
        • Gonzalez-Juanatey JR
        • Harjola VP
        • Jankowska EA
        • Jessup M
        • Linde C
        • Nihoyannopoulos P
        • Parissis JT
        • Pieske B
        • Riley JP
        • Rosano GM
        • Ruilope LM
        • Ruschitzka F
        • Rutten FH
        • van der Meer P
        • Authors/Task Force M, Document R
        2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2016; 37: 2129-2200
        • Koh AS
        • Tay WT
        • Teng THK
        • Vedin O
        • Benson L
        • Dahlstrom U
        • Savarese G
        • Lam CSP
        • Lund LH
        A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
        Eur J Heart Fail. 2017; 19: 1624-1634
        • Jonsson A
        • Edner M
        • Alehagen U
        • Dahlstrom U
        Heart failure registry: a valuable tool for improving the management of patients with heart failure.
        Eur J Heart Fail. 2010; 12: 25-31
        • Runesson B
        • Gasparini A
        • Qureshi AR
        • Norin O
        • Evans M
        • Barany P
        • Wettermark B
        • Elinder CG
        • Carrero JJ
        The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.
        Clin Kidney J. 2016; 9: 119-127
        • Valente MA
        • Hillege HL
        • Navis G
        • Voors AA
        • Dunselman PH
        • van Veldhuisen DJ
        • Damman K
        The chronic kidney disease epidemiology collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure.
        Eur J Heart Fail. 2014; 16: 86-94
        • Ueda T
        • Kawakami R
        • Sugawara Y
        • Okada S
        • Nishida T
        • Onoue K
        • Soeda T
        • Okayama S
        • Takeda Y
        • Watanabe M
        • Kawata H
        • Uemura S
        • Saito Y
        Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
        JAHA. 2014; 3e001174
        • Metra M
        • Gheorghiade M
        • Bonow RO
        • Dei Cas L
        Postdischarge assessment after a heart failure hospitalization: the next step forward.
        Circulation. 2010; 122: 1782-1785
        • Lofman I
        • Szummer K
        • Dahlstrom U
        • Jernberg T
        • Lund LH
        Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
        Eur J Heart Fail. 2017; 19: 1606-1614
        • Ter Maaten JM
        • Damman K
        • Verhaar MC
        • Paulus WJ
        • Duncker DJ
        • Cheng C
        • van Heerebeek L
        • Hillege HL
        • Lam CS
        • Navis G
        • Voors AA
        Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
        Eur J Heart Fail. 2016; 18: 588-598
        • Damman K
        • van Deursen VM
        • Navis G
        • Voors AA
        • van Veldhuisen DJ
        • Hillege HL
        Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
        J Am Coll of Cardiol. 2009; 53: 582-588
        • Gorter TM
        • van Veldhuisen DJ
        • Bauersachs J
        • Borlaug BA
        • Celutkiene J
        • Coats AJS
        • Crespo-Leiro MG
        • Guazzi M
        • Harjola VP
        • Heymans S
        • Hill L
        • Lainscak M
        • Lam CSP
        • Lund LH
        • Lyon AR
        • Mebazaa A
        • Mueller C
        • Paulus WJ
        • Pieske B
        • Piepoli MF
        • Ruschitzka F
        • Rutten FH
        • Seferovic PM
        • Solomon SD
        • Shah SJ
        • Triposkiadis F
        • Wachter R
        • Tschope C
        • de Boer RA
        Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
        Eur J Heart Fail. 2018; 20: 16-37
        • Unger ED
        • Dubin RF
        • Deo R
        • Daruwalla V
        • Friedman JL
        • Medina C
        • Beussink L
        • Freed BH
        • Shah SJ
        Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
        Eur J Heart Fail. 2016; 18: 103-112
        • Klein DA
        • Katz DH
        • Beussink-Nelson L
        • Sanchez CL
        • Strzelczyk TA
        • Shah SJ
        Association of chronic kidney disease with chronotropic incompetence in heart failure with preserved ejection fraction.
        Am J Cardiol. 2015; 116: 1093-1100
        • Rossignol P
        • Dobre D
        • McMurray JJ
        • Swedberg K
        • Krum H
        • van Veldhuisen DJ
        • Shi H
        • Messig M
        • Vincent J
        • Girerd N
        • Bakris G
        • Pitt B
        • Zannad F
        Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
        Circ Heart Fail. 2014; 7: 51-58
        • Vedin O
        • Lam CSP
        • Koh AS
        • Benson L
        • Teng THK
        • Tay WT
        • Braun OO
        • Savarese G
        • Dahlstrom U
        • Lund LH
        Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study.
        Circ Heart Fail. 2017; 10
        • Nauta JF
        • Hummel YM
        • van Melle JP
        • van der Meer P
        • Lam CSP
        • Ponikowski P
        • Voors AA
        What have we learned about heart failure with mid-range ejection fraction one year after its introduction?.
        Eur J Heart Fail. 2017; 19: 1569-1573
        • Palazzuoli A
        • Lombardi C
        • Ruocco G
        • Padeletti M
        • Nuti R
        • Metra M
        • Ronco C
        Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?.
        Eur Heart J Acute Cardiovasc Care. 2016; 5: 534-548